JPY 4759.0
(-0.69%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 54.37 Billion JPY | -21.62% |
2022 | 69.37 Billion JPY | 76.19% |
2021 | 39.37 Billion JPY | 31.26% |
2020 | 30 Billion JPY | -29.24% |
2019 | 42.39 Billion JPY | 7.66% |
2018 | 39.37 Billion JPY | 0.0% |
2017 | 39.37 Billion JPY | 61.54% |
2016 | 24.37 Billion JPY | 62.51% |
2015 | 15 Billion JPY | 0.0% |
2014 | 15 Billion JPY | 0.0% |
2013 | - JPY | 0.0% |
2012 | - JPY | 0.0% |
2011 | - JPY | 0.0% |
2010 | - JPY | 0.0% |
2009 | - JPY | 0.0% |
2008 | - JPY | -100.0% |
2007 | 2.06 Billion JPY | -66.55% |
2006 | 6.18 Billion JPY | -47.71% |
2005 | 11.83 Billion JPY | -36.72% |
2004 | 18.69 Billion JPY | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 54.37 Billion JPY | 0.0% |
2023 Q4 | 54.37 Billion JPY | 0.0% |
2023 FY | 54.37 Billion JPY | -21.62% |
2023 Q3 | 54.37 Billion JPY | -21.62% |
2023 Q2 | 69.37 Billion JPY | 0.0% |
2023 Q1 | 69.37 Billion JPY | 0.0% |
2022 FY | 69.37 Billion JPY | 76.19% |
2022 Q1 | 39.37 Billion JPY | 0.0% |
2022 Q3 | 69.37 Billion JPY | 0.0% |
2022 Q2 | 69.37 Billion JPY | 76.19% |
2022 Q4 | 69.37 Billion JPY | 0.0% |
2021 Q2 | 39.37 Billion JPY | 31.26% |
2021 FY | 39.37 Billion JPY | 31.26% |
2021 Q4 | 39.37 Billion JPY | 0.0% |
2021 Q1 | 30 Billion JPY | 0.0% |
2021 Q3 | 39.37 Billion JPY | 0.0% |
2020 Q3 | 33 Billion JPY | -0.0% |
2020 Q2 | 33 Billion JPY | -22.15% |
2020 FY | 30 Billion JPY | -29.24% |
2020 Q1 | 42.39 Billion JPY | 0.0% |
2020 Q4 | 30 Billion JPY | -9.1% |
2019 Q3 | 39.37 Billion JPY | 0.0% |
2019 FY | 42.39 Billion JPY | 7.66% |
2019 Q1 | 39.37 Billion JPY | 0.0% |
2019 Q4 | 42.39 Billion JPY | 7.66% |
2019 Q2 | 39.37 Billion JPY | 0.0% |
2018 FY | 39.37 Billion JPY | 0.0% |
2018 Q4 | 39.37 Billion JPY | 0.0% |
2018 Q3 | 39.37 Billion JPY | 0.0% |
2018 Q2 | 39.37 Billion JPY | 0.0% |
2018 Q1 | 39.37 Billion JPY | 0.0% |
2017 FY | 39.37 Billion JPY | 61.54% |
2017 Q1 | 39.37 Billion JPY | 61.54% |
2017 Q2 | 39.37 Billion JPY | 0.0% |
2017 Q4 | 39.37 Billion JPY | 0.0% |
2017 Q3 | 39.37 Billion JPY | 0.0% |
2016 Q1 | 15 Billion JPY | 0.0% |
2016 FY | 24.37 Billion JPY | 62.51% |
2016 Q3 | 24.37 Billion JPY | 62.51% |
2016 Q4 | 24.37 Billion JPY | 0.0% |
2016 Q2 | 15 Billion JPY | 0.0% |
2015 Q2 | 15 Billion JPY | 0.0% |
2015 FY | 15 Billion JPY | 0.0% |
2015 Q1 | 15 Billion JPY | 0.0% |
2015 Q3 | 15 Billion JPY | 0.0% |
2015 Q4 | 15 Billion JPY | 0.0% |
2014 FY | 15 Billion JPY | 0.0% |
2014 Q4 | 15 Billion JPY | 0.0% |
2014 Q3 | 15 Billion JPY | 0.0% |
2014 Q2 | 15 Billion JPY | 0.0% |
2014 Q1 | 15 Billion JPY | 0.0% |
2013 Q3 | - JPY | 0.0% |
2013 Q4 | - JPY | 0.0% |
2013 FY | - JPY | 0.0% |
2013 Q2 | - JPY | 0.0% |
2013 Q1 | - JPY | 0.0% |
2012 Q3 | - JPY | 0.0% |
2012 Q4 | - JPY | 0.0% |
2012 Q1 | - JPY | 0.0% |
2012 Q2 | - JPY | 0.0% |
2012 FY | - JPY | 0.0% |
2011 Q3 | - JPY | 0.0% |
2011 FY | - JPY | 0.0% |
2011 Q1 | - JPY | 0.0% |
2011 Q2 | - JPY | 0.0% |
2011 Q4 | - JPY | 0.0% |
2010 Q2 | - JPY | 0.0% |
2010 Q1 | - JPY | 0.0% |
2010 FY | - JPY | 0.0% |
2010 Q4 | - JPY | 0.0% |
2010 Q3 | - JPY | 0.0% |
2009 Q4 | - JPY | 0.0% |
2009 Q2 | - JPY | 0.0% |
2009 Q3 | - JPY | 0.0% |
2009 FY | - JPY | 0.0% |
2008 Q3 | 39 Million JPY | 0.0% |
2008 FY | - JPY | -100.0% |
2008 Q4 | - JPY | -100.0% |
2007 FY | 2.06 Billion JPY | -66.55% |
2006 FY | 6.18 Billion JPY | -47.71% |
2005 FY | 11.83 Billion JPY | -36.72% |
2004 FY | 18.69 Billion JPY | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 1.23 Billion JPY | -4317.303% |
Takeda Pharmaceutical Company Limited | 4476.5 Billion JPY | 98.785% |
Sumitomo Pharma Co., Ltd. | 133.36 Billion JPY | 59.228% |
Shionogi & Co., Ltd. | 8.75 Billion JPY | -521.238% |
Wakamoto Pharmaceutical Co.,Ltd. | - JPY | -Infinity% |
Nippon Shinyaku Co., Ltd. | 1.15 Billion JPY | -4620.226% |
Kaken Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
Eisai Co., Ltd. | 134.77 Billion JPY | 59.653% |
Morishita Jintan Co., Ltd. | 106 Million JPY | -51199.057% |
Hisamitsu Pharmaceutical Co., Inc. | 76 Million JPY | -71448.684% |
Mochida Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
Fuso Pharmaceutical Industries,Ltd. | 7.02 Billion JPY | -674.491% |
Nippon Chemiphar Co., Ltd. | 13.34 Billion JPY | -307.501% |
Kissei Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
Torii Pharmaceutical Co., Ltd. | 22 Million JPY | -247068.182% |
Towa Pharmaceutical Co., Ltd. | 189.12 Billion JPY | 71.248% |
Fuji Pharma Co., Ltd. | 11.92 Billion JPY | -356.03% |
Zeria Pharmaceutical Co., Ltd. | 7.94 Billion JPY | -584.521% |
KYORIN Holdings, Inc. | 435 Million JPY | -12400.46% |
Taiko Pharmaceutical Co.,Ltd. | 2.74 Billion JPY | -1883.838% |
Daito Pharmaceutical Co.,Ltd. | 4.66 Billion JPY | -1064.639% |
SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
MedRx Co., Ltd | - JPY | -Infinity% |
Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
Solasia Pharma K.K. | 27 Million JPY | -201296.296% |
Modalis Therapeutics Corporation | 412.5 Million JPY | -13082.303% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 4.5 Billion JPY | -1107.037% |
Sawai Group Holdings Co., Ltd. | 66.84 Billion JPY | 18.647% |
Cyfuse Biomedical K.K. | 345 Million JPY | -15661.449% |
Toho Holdings Co., Ltd. | 28.16 Billion JPY | -93.059% |
Koa Shoji Holdings Co.,Ltd. | 1.59 Billion JPY | -3316.963% |